Vivanza Biosciences Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 83.3% YoY
Vivanza Biosciences Ltd reported revenue from operations of ₹11.4 Cr (-79.4% YoY) and net profit of ₹0.1 Cr (-83.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr · -83.3% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Vivanza Biosciences Ltd reported revenue from operations of ₹11.4 Cr (-79.4% YoY) and net profit of ₹0.1 Cr (-83.3% YoY) for Q2 FY27.
Vivanza Biosciences Ltd reported revenue from operations of ₹9.3 Cr (+4.5% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
Vivanza Biosciences Ltd reported revenue from operations of ₹6.4 Cr (+1180.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.
Vivanza Biosciences reported audited standalone annual revenue of ₹112.34 Crore. The Board also noted resignations of its Director and Company Secretary during the meeting.